AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Epotop 40000IU Injection

Prescription Icon
Prescription Required

Marketer

Vhb Life Sciences Inc

Salt Composition

Recombinant Human Erythropoietin Alfa (40000IU)

Overview Epotop 40000IU Injection

Erythropoietin (Epotop 40000IU) injection stimulates red blood cell production within the bone marrow. Its primary application is in treating anemia stemming from kidney disease. It's also indicated for anemia resulting from cancer chemotherapy or antiretroviral HIV medications. Administration, either subcutaneous or intravenous, is determined by your physician and typically performed by a healthcare professional. Dosage is tailored to your weight and the underlying anemia cause. Concurrent iron supplementation enhances treatment efficacy. Store Epotop 40000IU in a refrigerator but allow it to reach room temperature before injection. Common side effects include nausea, vomiting, fever, and elevated blood pressure; flu-like symptoms such as headache, fatigue, dizziness, and myalgia may also occur, frequently subsiding as treatment progresses. Report serious side effects, including convulsions, immediately. Serious blood clots, requiring immediate medical intervention, are a potential, albeit rare, complication. Inform your doctor of uncontrolled hypertension, heart conditions, or gout before commencing treatment, and disclose all other medications. Regular blood pressure monitoring is crucial, along with periodic blood tests to assess for adverse effects. The drug's impact on fetal development remains undetermined; notify your physician if pregnant, planning pregnancy, or breastfeeding.

Uses of Epotop 40000IU Injection

Managing Anemia in Cancer Chemotherapy Patients | Addressing Anemia in Chronic Kidney Disease

Major Benefits of Epotop 40000IU Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Epotop 40000IU Injection:

  • High blood pressure
  • Nausea
  • Vomiting
  • Fever
  • Rash
  • Joint pain
  • Headache
  • Insomnia (difficulty in sleeping)
  • Chills
  • Cough
  • Bone pain
  • Muscle spasm
  • Dizziness
  • Vascular occlusion
  • Injection site irritation
  • Stomatitis (Inflammation of the mouth)
  • Weight loss
  • Decreased white blood cell count (lymphocytes)
  • Increased glucose level in blood
  • Blood clot in the blood vessels

How to use Epotop 40000IU Injection:

Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.

How Epotop 40000IU Injection works:

Epotop 40000IU Injection is an erythropoietin-based medication that boosts red blood cell production. This action stimulates the bone marrow, the blood cell-producing tissue within bones, to increase red blood cell output.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Epotop 40000IU Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Epotop 40000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Epotop 40000IU Injection while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administering Epotop 40000IU Injection may result in adverse reactions that could impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney disease, administration of Epotop 40000IU Injection is considered safe and does not require dosage modification. Routine monitoring of renal function is, however, recommended during treatment.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Epotop 40000IU Injection. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Epotop 40000IU Injection :

Omitting a scheduled dose of Epotop 40000IU Injection warrants immediate physician consultation.

Facts to Know About Epotop 40000IU Injection

LabelValue
Chemical Category Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Epotop 40000IU Injection

Hospital storage for unopened Epotop 40000IU pre-filled syringes is refrigerated (2-8°C). Home storage also requires refrigeration; freezing is prohibited. Before use, allow the syringe to reach room temperature (15-30 minutes). Used or soon-to-be-used syringes may remain at room temperature (below 25°C) for up to 7 days. Keep out of reach of children and protected from light.
Inform your doctor or nurse immediately if you suspect an Epotop 40000IU Injection overdose.
Do not use Epotop 40000IU Injection if the solution is cloudy, contains particles, or is expired (check the expiry date). Avoid use if you suspect freezing or refrigerator malfunction.
Epotop 40000IU Injection treats anemia resulting from chronic kidney disease in children over one year old. Its efficacy and side effects in children mirror those observed in adults.
Epotop 40000IU Injection can influence blood pressure. Blood pressure monitoring is crucial during initial treatment; patients with hypertension should manage their condition accordingly. The doctor may discontinue Epotop 40000IU Injection if blood pressure remains uncontrolled.
Epotop 40000IU Injection
9,312
MRP 10,265
9% off